These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 9261198)

  • 21. Dilute oral iron solutions as gastrointestinal contrast agents for magnetic resonance imaging; initial clinical experience.
    Wesbey GE; Brasch RC; Goldberg HI; Engelstad BL; Moss AA
    Magn Reson Imaging; 1985; 3(1):57-64. PubMed ID: 3923293
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical use of contrast media in magnetic resonance imaging.
    Bydder GM
    Br J Hosp Med; 1990 Feb; 43(2):149-52. PubMed ID: 2178714
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Technical note: dynamic analysis of the pharynx during swallowing using Turbo-FLASH magnetic resonance imaging combined with an oral positive contrast agent--a preliminary study.
    Suto Y; Kamba M; Kato T
    Br J Radiol; 1995 Oct; 68(814):1099-102. PubMed ID: 7496712
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Large scale clinical evaluation of bowel contrast agent containing ferric ammonium citrate in MRI.
    Hirohashi S; Uchida H; Yoshikawa K; Fujita N; Ohtomo K; Yuasa Y; Kawamura Y; Matsui O
    Magn Reson Imaging; 1994; 12(6):837-46. PubMed ID: 7968283
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MR contrast agents, the old and the new.
    Bellin MF
    Eur J Radiol; 2006 Dec; 60(3):314-23. PubMed ID: 17005349
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular magnetic resonance imaging with targeted contrast agents.
    Artemov D
    J Cell Biochem; 2003 Oct; 90(3):518-24. PubMed ID: 14523986
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ferric ammonium citrate as a positive bowel contrast agent for MR imaging of the upper abdomen. Safety and diagnostic efficacy.
    Kivelitz D; Gehl HB; Heuck A; Krahe T; Taupitz M; Lodemann KP; Hamm B
    Acta Radiol; 1999 Jul; 40(4):429-35. PubMed ID: 10394873
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular imaging with targeted contrast agents.
    Makowski MR; Wiethoff AJ; Jansen CH; Botnar RM
    Top Magn Reson Imaging; 2009 Aug; 20(4):247-59. PubMed ID: 20805735
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Imaging of inflammation in the peripheral and central nervous system by magnetic resonance imaging.
    Stoll G; Bendszus M
    Neuroscience; 2009 Feb; 158(3):1151-60. PubMed ID: 18651996
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of scaffolds for tissue engineering by benchtop-magnetic resonance imaging.
    Nitzsche H; Metz H; Lochmann A; Bernstein A; Hause G; Groth T; Mäder K
    Tissue Eng Part C Methods; 2009 Sep; 15(3):513-21. PubMed ID: 19191523
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Elimination of bowel fluid artifact on abdominal DWI using oral contrast agent ferric ammonium citrate].
    Takahashi T; Kato K; Nishizawa T; Nakazawa Y
    Nihon Hoshasen Gijutsu Gakkai Zasshi; 2008 May; 64(5):573-8. PubMed ID: 18509218
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Double-contrast magnetic resonance imaging of the small and large bowel: effectiveness in the evaluation of inflammatory bowel disease.
    Maccioni F
    Abdom Imaging; 2010 Feb; 35(1):31-40. PubMed ID: 19082651
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Usage of the T1 effect of an iron oxide contrast agent in an animal model to quantify myocardial blood flow by MRI.
    Lüdemann L; Schmitt B; Podrabsky P; Schnackenburg B; Böck J; Gutberlet M
    Eur J Radiol; 2007 May; 62(2):247-56. PubMed ID: 17188443
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cell tracking using magnetic resonance imaging.
    Hoehn M; Wiedermann D; Justicia C; Ramos-Cabrer P; Kruttwig K; Farr T; Himmelreich U
    J Physiol; 2007 Oct; 584(Pt 1):25-30. PubMed ID: 17690140
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Magnetic resonance relaxation properties of superparamagnetic particles.
    Gossuin Y; Gillis P; Hocq A; Vuong QL; Roch A
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2009; 1(3):299-310. PubMed ID: 20049798
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical applications of contrast agents in body imaging.
    Bydder GM
    Top Magn Reson Imaging; 1991 Mar; 3(2):74-84. PubMed ID: 2025434
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Kupffer cell function of hepatocellular adenoma: pulse sequence effects in superparamagnetic iron oxide-enhanced magnetic resonance imaging.
    Akatsu T; Ueda M; Shimazu M; Wakabayashi G; Aiura K; Tanabe M; Kawachi S; Tanimoto A; Shinmoto H; Sakamoto M; Kitajima M
    J Gastroenterol Hepatol; 2004 Aug; 19(8):951-2. PubMed ID: 15242510
    [No Abstract]   [Full Text] [Related]  

  • 38. [Lymph node diagnosis with imaging methods. An overview with special reference to recent developments in the area of MR contrast media].
    Mohr U; Weissleder R
    Z Lymphol; 1996 Jun; 20(1):15-20. PubMed ID: 8768044
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ferrite particles as an MR contrast agent.
    Saini S; Ferrucci JT
    Radiology; 1988 Dec; 169(3):656. PubMed ID: 3186987
    [No Abstract]   [Full Text] [Related]  

  • 40. The clinical value of ferric ammonium citrate: a positive oral contrast agent for T1-weighted MR imaging of the upper abdomen.
    Malcolm PN; Brown JJ; Hahn PF; Stillman AE; Li KC; Kawamura Y; Tanaka T; Noel JK; Molony BA; Johnson MF; Hildebolt CF
    J Magn Reson Imaging; 2000 Nov; 12(5):702-7. PubMed ID: 11050639
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.